Introduction: The basis for the superior absorption of iron from breast milk compared with infant formulas is unclear. The hormone hepcidin downregulates dietary iron absorption. Hepcidin production increases with increased body iron status (reflected in serum ferritin levels). We hypothesized that serum hepcidin levels are suppressed relative to iron status in infants fed breast milk compared with formula. Methods: Subjects were healthy infants presenting for routine 2-month clinic visit and strictly fed either breast milk or standard infant formula. Urinary hepcidin and ferritin levels (reflective of serum levels) were analyzed and compared across the breast milk- and formula-fed groups. The relationship between urinary hepcidin and ferritin levels within each group was analyzed by linear regression. Results: Twenty-four subjects were enrolled in each group. The median urinary hepcidin level in the group fed breast milk was lower than in formula (130 vs. 359 ng hepcidin/mg creatinine, p < 0.05). However, the median ferritin levels were similar (2.1 vs. 1.9 ng/mL). Within each group, urinary hepcidin correlated with urinary ferritin (r = 0.5, p < 0.05 for each group); however, the slope of the regression line was lower in the group fed breast milk compared with formula (p < 0.005). Conclusion: Despite similar urinary ferritin levels, urinary hepcidin levels are lower at 2 months in infants fed breast milk compared with infants fed formula. Hepcidin levels correlate with iron status in each group; however, this relationship is relatively dampened in infants fed breast milk. We speculate that relatively lower infant hepcidin contributes to the superior efficiency of iron absorption from breast milk.

1.
Georgieff
MK
,
Krebs
NF
,
Cusick
SE
.
The Benefits and Risks of Iron Supplementation in Pregnancy and Childhood
.
Annu Rev Nutr
.
2019
Aug
;
39
(
1
):
121
46
.
[PubMed]
0199-9885
2.
McDonagh
MS
,
Blazina
I
,
Dana
T
,
Cantor
A
,
Bougatsos
C
.
Screening and Routine Supplementation for Iron Deficiency Anemia: A Systematic Review.
Pediatrics.
2015
:peds.2014-3979.
3.
Siu
AL
;
US Preventive Services Task Force
.
Screening for Iron Deficiency Anemia in Young Children: USPSTF Recommendation Statement
.
Pediatrics
.
2015
Oct
;
136
(
4
):
746
52
.
[PubMed]
0031-4005
4.
Taylor
SN
. ABM Clinical Protocol #29: Iron, Zinc, and Vitamin D Supplementation During Breastfeeding. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.
2018
;13(6):398-404.
5.
Baker
RD
,
Greer
FR
;
Committee on Nutrition American Academy of Pediatrics
.
Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age)
.
Pediatrics
.
2010
Nov
;
126
(
5
):
1040
50
.
[PubMed]
0031-4005
6.
Domellöf
M
,
Lönnerdal
B
,
Abrams
SA
,
Hernell
O
.
Iron absorption in breast-fed infants: effects of age, iron status, iron supplements, and complementary foods
.
Am J Clin Nutr
.
2002
Jul
;
76
(
1
):
198
204
.
[PubMed]
0002-9165
7.
Saarinen
UM
,
Siimes
MA
.
Iron absorption from infant milk formula and the optimal level of iron supplementation
.
Acta Paediatr Scand
.
1977
Nov
;
66
(
6
):
719
22
.
[PubMed]
0001-656X
8.
American Academy of Pediatrics. Committee on Nutrition
.
Iron fortification of infant formulas
.
Pediatrics
.
1999
Jul
;
104
(
1 Pt 1
):
119
23
.
[PubMed]
0031-4005
9.
Paganini
D
,
Zimmermann
MB
.
The effects of iron fortification and supplementation on the gut microbiome and diarrhea in infants and children: a review
.
Am J Clin Nutr
.
2017
Dec
;
106
Suppl 6
:
1688S
93S
.
[PubMed]
0002-9165
10.
Iron Fact Sheet for Professionals Bethesda, Maryland: National Institutes of Health Office of Dietary Supplements;
2018
[Available from: https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/
11.
Board IoMFaN
.
Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc: a Report of the Panel on Micronutrients
.
Washington (DC)
:
National Academy Press
;
2001
.
12.
Ganz
T
.
Systemic iron homeostasis
.
Physiol Rev
.
2013
Oct
;
93
(
4
):
1721
41
.
[PubMed]
0031-9333
13.
Ganz
T
,
Olbina
G
,
Girelli
D
,
Nemeth
E
,
Westerman
M
.
Immunoassay for human serum hepcidin
.
Blood
.
2008
Nov
;
112
(
10
):
4292
7
.
[PubMed]
0006-4971
14.
Müller
KF
,
Lorenz
L
,
Poets
CF
,
Westerman
M
,
Franz
AR
.
Hepcidin concentrations in serum and urine correlate with iron homeostasis in preterm infants
.
J Pediatr
.
2012
Jun
;
160
(
6
):
949
53.e2
.
[PubMed]
0022-3476
15.
Lipschitz
DA
,
Cook
JD
,
Finch
CA
.
A clinical evaluation of serum ferritin as an index of iron stores
.
N Engl J Med
.
1974
May
;
290
(
22
):
1213
6
.
[PubMed]
0028-4793
16.
Bahr
TM
,
Christensen
RD
,
Ward
DM
,
Meng
F
,
Jackson
LK
,
Doyle
K
, et al
Ferritin in serum and urine: A pilot study
.
Blood Cells Mol Dis
.
2019
May
;
76
:
59
62
.
[PubMed]
1079-9796
17.
Fomon
SJ
,
Ziegler
EE
,
Nelson
SE
,
Serfass
RE
,
Frantz
JA
.
Erythrocyte incorporation of iron by 56-day-old infants fed a 58Fe-labeled supplement
.
Pediatr Res
.
1995
Sep
;
38
(
3
):
373
8
.
[PubMed]
0031-3998
18.
McMillan
JA
,
Oski
FA
,
Lourie
G
,
Tomarelli
RM
,
Landaw
SA
.
Iron absorption from human milk, simulated human milk, and proprietary formulas
.
Pediatrics
.
1977
Dec
;
60
(
6
):
896
900
.
[PubMed]
0031-4005
19.
Ronis
MJ
,
Chen
Y
,
Shankar
K
,
Gomez-Acevedo
H
,
Cleves
MA
,
Badeaux
J
, et al
Formula feeding alters hepatic gene expression signature, iron and cholesterol homeostasis in the neonatal pig
.
Physiol Genomics
.
2011
Dec
;
43
(
23
):
1281
93
.
[PubMed]
1094-8341
20.
Uijterschout
L
,
Domellöf
M
,
Berglund
SK
,
Abbink
M
,
Vos
P
,
Rövekamp
L
, et al
Serum hepcidin in infants born after 32 to 37 wk of gestational age
.
Pediatr Res
.
2016
Apr
;
79
(
4
):
608
13
.
[PubMed]
0031-3998
21.
Saarinen
UM
,
Siimes
MA
.
Serum ferritin in assessment of iron nutrition in healthy infants
.
Acta Paediatr Scand
.
1978
Nov
;
67
(
6
):
745
51
.
[PubMed]
0001-656X
22.
Li
R
,
Perrine
CG
,
Anstey
EH
,
Chen
J
,
MacGowan
CA
,
Elam-Evans
LD
.
Breastfeeding Trends by Race/Ethnicity Among US Children Born From 2009 to 2015
.
JAMA Pediatr
.
2019
Oct
;
173
(
12
):
e193319
.
[PubMed]
2168-6203
23.
Hill
DR
,
Newburg
DS
.
Clinical applications of bioactive milk components
.
Nutr Rev
.
2015
Jul
;
73
(
7
):
463
76
.
[PubMed]
0029-6643
24.
Srivastava
MD
,
Srivastava
A
,
Brouhard
B
,
Saneto
R
,
Groh-Wargo
S
,
Kubit
J
.
Cytokines in human milk
.
Res Commun Mol Pathol Pharmacol
.
1996
Sep
;
93
(
3
):
263
87
.
[PubMed]
1078-0297
25.
Goodnough
JB
,
Ramos
E
,
Nemeth
E
,
Ganz
T
.
Inhibition of hepcidin transcription by growth factors
.
Hepatology
.
2012
Jul
;
56
(
1
):
291
9
.
[PubMed]
0270-9139
26.
Kainonen
E
,
Rautava
S
,
Isolauri
E
.
Immunological programming by breast milk creates an anti-inflammatory cytokine milieu in breast-fed infants compared to formula-fed infants
.
Br J Nutr
.
2013
Jun
;
109
(
11
):
1962
70
.
[PubMed]
0007-1145
27.
Ossa
JC
,
Yáñez
D
,
Valenzuela
R
,
Gallardo
P
,
Lucero
Y
,
Farfán
MJ
;
Breast Milk and Its Association With Their Gut Microbiota
.
Intestinal Inflammation in Chilean Infants Fed With Bovine Formula vs
.
Front Cell Infect Microbiol
.
2018
Jun
;
8
:
190
.
[PubMed]
2235-2988
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.